All terms in BAO
Label | Id | Description |
---|---|---|
concentration endpoint | BAO_0000180 | [It can refer to the screening concentration (for example in a primary assay) or it can be a concentration at which the perturbagen mediates a defined response, such as IC50 or EC50. It always has one value and a concentration unit.] |
measure group | BAO_0000040 | [Measure group is used to group and link multiple (different) sets of experimental results to one bioassay. Measure groups thus facilitate the description of multiparametric (or multiplexed) assays, that measure more than one effect of the perturbagen on the system that is screened. It also facilitate the definition of panel and profiling assays, e.g. assays that test compounds against multiple (protein) targets. Compare definition of bioassay. Measure group links to those classes that can vary among different measurements of a panel assay, profiling assay, multiparametric assay, e.g. target, assay design method, physical detection method, endpoint. Measure group is also used to define derived endpoints, for example concentration-response endpoints obtained by curve fitting a set of results from the same compound tested in the same assay at different concentrations.] |
screening campaign | BAO_0000178 | [Screening campaign incudes a sequence of (assay) experiments performed to identify a compound (or a series of compounds) with a specific function and it is desirable to have a known mechanism of action. It includes primary (screening at single concentration), secondary, and confirmatory (dose response) screens, structure activity relationship (SAR) studies, lead optimization, etc.] |
experimental specification | BAO_0002933 | |
small molecule | BAO_0000176 | [Small molecule is an organic compound with a low molecular weight (<800 Da) which is used to screen against a biological target, e.g. protein, nucleic acid, cell or organism to test its ability to bind it and bring about a change in activity. It is either isolated from a natural source or is synthesized.] |
screened entity | BAO_0000076 | |
protein | BAO_0000175 | [A protein or polypeptide is a long polymer of amino acids joined together by peptide bonds. The sequence of the amino acids is defined by the genetic code. Here, a protein is a perturbagen whereby its ability to modulate a physiological process or a disease pathology is assessed.] |
protein preparation method | BAO_0000356 | [This describes the method by which a protein is purified from its source.] |
peptide | BAO_0000325 | [Peptide is a short polymer of amino acids, which is generally <50 amino acids long.] |
peptoid | BAO_0000174 | [Peptoids are a class of biomimetic polymers based on oligo-N-substituted glycine backbones, designed to mimic peptides and proteins. Peptoids are resistant to proteolysis and not typically denatured by solvent, temperature, or chemical denaturants.] |
ACTOne Membrane Potential Dye | BAO_0000172 | |
dye | CHEBI_37958 | |
transient arthritis | DOID_2092 | |
arthropathy | DOID_381 | [A bone inflammation disease that is located_in joint.] |
vulvar melanoma | DOID_2093 | |
vulva cancer | DOID_1245 | |
sweat gland cancer | DOID_2095 | |
sweat gland disease | DOID_1383 | |
skin cancer | DOID_4159 | [An integumentary system cancer located_in the skin that is the uncontrolled growth of abnormal skin cells.] |
percent control | BAO_0000143 | [Percent control is the response relative to a reference state, typically to a high control. For example it can describe (remaining) activity of a kinase (or e.g. kinase bound to substrate). Percent control could also quantify an inhibitory action depending on control and assay method.] |